[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364907-105":59,"doc-detail-364907-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","microrna-99-family-in-cancer-molecular-mechanisms-for-clinical-applications","MicroRNA-99 family in cancer: molecular mechanisms for clinical applications","","MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression post-transcriptionally. The evolutionarily conserved miR-99 family includes miR-99a, miR-99b, and miR-100, and is often under-expressed in cancerous tissues, supporting cancer-repressive roles across multiple malignancies while showing context-dependent pro-tumor effects. Family members target many genes governing tumorigenesis, proliferation, cell-cycle control, apoptosis, invasion, and metastasis, with review coverage of biomarker and therapeutic potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microrna-99-family-in-cancer-molecular-mechanisms-for-clinical-applications/364907/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microrna-99-family-in-cancer-molecular-mechanisms-for-clinical-applications/364907.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the miR-99 family and how does it function in gene regulation?","Question",{"text":113,"@type":114},"The miR-99 family consists of miR-99a, miR-99b, and miR-100. As microRNAs, they regulate gene expression post-transcriptionally by targeting mRNAs through seed-sequence recognition and associated mechanisms.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"In what ways are miR-99 family members linked to cancer biology?",{"text":118,"@type":114},"Members target numerous genes involved in tumorigenesis, proliferation, cell-cycle regulation, apoptosis, invasion, and metastasis. Their expression is under-expressed in many cancer contexts, yet in some settings they can also promote malignant progression.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the review position the miR-99 family for clinical use?",{"text":122,"@type":114},"The review summarizes research implications and explores clinical translation, emphasizing the family’s potential as a biomarker and as a cancer therapeutic target.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364907,1790196710,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":24,"preview_urls":147},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","1  \n2  \nSubmitted 16 September 2024 Accepted 25 February 2025 Published 27 March 2025  \nCorresponding author  \nMing Yang, [yangming@jlu.edu.cn](yangming@jlu.edu.cn)[ ](yangming@jlu.edu.cn)Academic editor  \nTokuko Haraguchi  \nAdditional Information and Declarations can be found on page 25  \nDOI 10.7717/peerj.19188  \n Copyright 2025 Wang et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nMicroRNA-99 family in cancer: molecular mechanisms for clinical applications  \nYueyuan Wang1, Dan Huang1, Mingxi Li2 and Ming Yang1  \nDepartment of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, ChangChun, Jilin, China  \nDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, ChangChun, Jilin, China  \nABSTRACT  \nMicroRNAs (miRNAs) are a class of non-coding RNA sequences that regulate gene expression post-transcriptionally. The miR-99 family, which is highly evolutionarily conserved, comprises three homologs: miR-99a, miR-99b, and miR-100 . Its members are under-expressed in most cancerous tissues, suggesting their cancer-repressing properties in multiple cancers; however, in some contexts, they also promote malignant lesion progression. MiR-99 family members target numerous genes involved in various tumor-related processes such as tumorigenesis, proliferation, cell-cycle regulation, apoptosis, invasion, and metastasis. We review the recent research on this family, summarize its implications in cancer, and explore its potential as a biomarker and cancer therapeutic target. This review contributes to the clinical translation of the miR-99 family members.  \nSubjects Biochemistry, Cell Biology, Molecular Biology, Oncology Keywords miR-99, Cancer, Resistance, Biomarker  \nINTRODUCTION  \nMicroRNAs (miRNAs) are endogenous, non-coding, single-stranded RNAs 18–25 nt in length. They recognize their targets via complementary binding between the “seed sequence”—an approximately 2–7 nt region at the 5′ end of the mature miRNAs, and a preferentially conserved site within the 3′-untranslated region of the mRNA (Friedmanet al., 2009) . Within the canonical machinery, miRNAs only degrade the mRNA of a target gene when entirely complementary. However, endogenously expressed miRNAs are typically not entirely complementary to their targets; they suppress target expression by inhibiting translation without affecting mRNA stability. Within the non-canonical machinery, miRNAs activate target mRNA translation directly or by binding to a conserved AU-rich sequence (Liu et al., 2023; Vasudevan, Tong & Steitz, 2007) . miRNA targets more than 5,300 human genes, which represented 30% of our gene set, and are involved in various processes, such as cell proliferation, differentiation, apoptosis, autophagy, immune responses, metabolic homeostasis, and tumorigenesis (Kloosterman & Plasterk, 2006; Lewis, Burge & Bartel, 2005) . Dysregulation of miRNAs has been increasingly detected in almost all types of cancer, indicating that miRNAs are pivotal factors in carcinogenesis (Kim & Croce, 2023) .  \nHow to cite this article Wang Y, Huang D, Li M, Yang M. 2025. MicroRNA-99 family in cancer: molecular mechanisms for clinical  \napplications. PeerJ 13:e19188 DOI 10.7717/peerj.19188  \nThe global cancer burden is increasing yearly, impacting millions of people and their families annually. Data from the International Agency for Research on Cancer indicate that in 2022, nearly 20 million new cancer cases emerged, accompanied by 9.7 million cancer-related deaths (Bray et al., 2024) . Combating the cancer burden demands a comprehensive strategy that takes into account the drawbacks of existing diagnostic and treatment approaches. Present diagnostic methods, like imaging and biopsy, frequently have deﬁciencies in terms of speciﬁcity and sensitivity. For example, conventional imaging might fail to detect early-stage tumors or yield false positives, causing unwarranted distress and invasive procedures for patients. Additiona","cbCait4kNPuexwAC","https://ap.wps.com/l/cbCait4kNPuexwAC","pdf",8509535,45,"English","# Abstract\n# Introduction\n# Survey Methodology","[{\"question\":\"What is the miR-99 family and how does it function in gene regulation?\",\"answer\":\"The miR-99 family consists of miR-99a, miR-99b, and miR-100. As microRNAs, they regulate gene expression post-transcriptionally by targeting mRNAs through seed-sequence recognition and associated mechanisms.\"},{\"question\":\"In what ways are miR-99 family members linked to cancer biology?\",\"answer\":\"Members target numerous genes involved in tumorigenesis, proliferation, cell-cycle regulation, apoptosis, invasion, and metastasis. Their expression is under-expressed in many cancer contexts, yet in some settings they can also promote malignant progression.\"},{\"question\":\"How does the review position the miR-99 family for clinical use?\",\"answer\":\"The review summarizes research implications and explores clinical translation, emphasizing the family’s potential as a biomarker and as a cancer therapeutic target.\"}]","MicroRNA-99 family in cancer: molecular mechanisms for clinical applications | PDF",1790159388,113,[148,152,156,160,164],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0c1de5a915303e110c4e2bea4e3af48.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bccb7748c494e30e5812d2ab95878f4.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2acd168043bd0cb0cfe8c29f725c9ffb.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbffcf1bfc156f96c0de0ddcfc65adf3.webp",980,1268,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a663f6021caab348db9b6c146b9361a6.webp",979,1267]